The premenstrual symptoms screening tool (PSST) for clinicians
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
A variety of instruments have been used in an attempt to operationalize DSM-IV criteria for premenstrual dysphoric disorder (PMDD) and to understand clinically significant premenstrual syndrome (PMS). The objectives of this research were to devise a simple user friendly screening tool to identify women who suffer from severe PMS/PMDD and who are likely to benefit from treatment. Five hundred and nineteen women, between the ages of 18 and 55 yrs, who were seen at a primary care facility completed "The Premenstrual Symptoms Screening tool" (PSST). The PSST reflects and 'translates' categorical DSM-IV criteria into a rating scale with degrees of severity. The results are in line with reported prevalence rates from several recent large prospective studies. We believe that the PSST applies a necessary degree of measure of severity and impact of premenstrual symptoms, establishes quickly if women qualify for PMDD, and is less time consuming and more practical than two cycles of prospective charting. This fast simple tool is an effective screening tool and an important starting point for further assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PMDD screening‐positive status was defined as a total score ≥ 28 on Item 1 of a validated PMDD assessment scale (12 items scored 1–4, total score 12–48) 14 , 15 .”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
WITTCHEN, H.-U., BECKER, E., LIEB, R., & KRAUSE, P. (2002) · Psychological Medicine · doi:10.1017/s0033291701004925 · Cited by 554 · cited 4×
“The results are in line with several recent prospective studies which report a prevalence of PMDD in a range of 4.6 to 8.1% and a prevalence of severe PMS in a range of 12.6% to 31.0% (Gehlert and Hartlage, 1997; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundResultInfluentialFluoxetine in the Treatment of Premenstrual Dysphoria
Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., & Streiner, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322301 · Cited by 445
Self-citationEfficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 2×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
BackgroundMethodGreene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 314
The epidemiology of perimenstrual psychological symptoms
Angst, J., Sellaro, R., Stolar, M., Merikangas, K. R., & Endicott, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00412.x · Cited by 300 · cited 4×
“The results are in line with several recent prospective studies which report a prevalence of PMDD in a range of 4.6 to 8.1% and a prevalence of severe PMS in a range of 12.6% to 31.0% (Gehlert and Hartlage, 1997; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundResultInfluentialBiological, Social, and Behavioral Factors Associated With Premenstrual Syndrome
Deuster, P. A. (1999) · Archives of Family Medicine · doi:10.1001/archfami.8.2.122 · Cited by 244 · cited 1×
“…differ in their interpretation of DSM-IV criteria, and definitions of clinically significant premenstrual symptoms are not comparable (Ramcharan et al., 1992; Gehlert and Hartlage, 1997; Deuster et al., 1999; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundMortola, J., Girton, L., Beck, L., & Yen, S. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90644-k · Cited by 221 · cited 1×
“There are at least 5 different diaries that have been used in recent years and there is no consensus as to which one is the preferred (Reid, 1985; Mortola et al., 1990; Endicott and Harrison, 1992; Freeman et al., 1996; Steiner et al., 1999.)”
BackgroundHYLAN, T. R., SUNDELL, K., & JUDGE, R. (1999) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/jwh.1.1999.8.1043 · Cited by 194 · cited 4×
“The results are in line with several recent prospective studies which report a prevalence of PMDD in a range of 4.6 to 8.1% and a prevalence of severe PMS in a range of 12.6% to 31.0% (Gehlert and Hartlage, 1997; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundResultInfluentialReliability and validity of a daily diary for premenstrual syndrome
Freeman, E. W., DeRubeis, R. J., & Rickels, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02929-0 · Cited by 177 · cited 2×
“There are at least 5 different diaries that have been used in recent years and there is no consensus as to which one is the preferred (Reid, 1985; Mortola et al., 1990; Endicott and Harrison, 1992; Freeman et al., 1996; Steiner et al., 1999.) Prospective daily charting has been used primarily in PMS=PMDD randomized cl…”
BackgroundMethodYonkers, K. A. (1997) · JAMA · doi:10.1001/jama.278.12.983 · Cited by 165 · cited 2×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodResultWikander, I., Sundblad, C., Andersch, B., Dagnell, I., Zylberstein, D., Bengtsson, F., & Eriksson, E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199810000-00007 · Cited by 164 · cited 1×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodEvaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M. (2001) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/15246090152543148 · Cited by 163 · cited 2×
“PMDD between women on and those not on hormonal contraceptives is in line with data which suggest that HC may reduce premenstrual physical symptoms but do not effect a statistically significant reduction in psychological symptoms (Backstrom et al., 1992; Graham and Sherwin, 1992; Freeman et al., 2001).”
ResultRamcharan, S., Love, E. J., Fick, G. H., & Goldfien, A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90039-p · Cited by 158 · cited 2×
“Existing studies differ in their interpretation of DSM-IV criteria, and definitions of clinically significant premenstrual symptoms are not comparable ( Ramcharan et al., 1992; Gehlert and Hartlage, 1997; Deuster et al., 1999; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundSundblad, C., Hedberg, M. A., & Eriksson, E. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.52 · Cited by 158 · cited 1×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodPearlstein, T. B., Halbreich, U., Batzar, E. D., Brown, C. S., Endicott, J., Frank, E., Freeman, E. W., Harrison, W. M., Haskett, R. F., Stout, A. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0205 · Cited by 156 · cited 3×
“The burden of illness of depression in the workplace has been well documented; findings suggest elevated rates of chronic disability, lost work days and diminished work performance in this population (Greenberg and Birnbaum, 2000; Pearlstein et al., 2000; Macdougall and Steiner, 2003).”
BackgroundMethodResultA prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive
Graham, C. A., & Sherwin, B. B. (1992) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(92)90090-o · Cited by 146 · cited 2×
“PMDD between women on and those not on hormonal contraceptives is in line with data which suggest that HC may reduce premenstrual physical symptoms but do not effect a statistically significant reduction in psychological symptoms (Backstrom et al., 1992; Graham and Sherwin, 1992; Freeman et al., 2001).”
ResultJohnson, S. R., McChesney, C., & Bean, J. A. (1988) · PubMed · Cited by 142
Severity of Premenstrual Symptoms in a Health Maintenance Organization Population
Sternfeld, B., Swindle, R. W., Chawla, A., Long, S., & Kennedy, S. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01958-0 · Cited by 139 · cited 4×
“The results are in line with several recent prospective studies which report a prevalence of PMDD in a range of 4.6 to 8.1% and a prevalence of severe PMS in a range of 12.6% to 31.0% (Gehlert and Hartlage, 1997; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundResultInfluentialCohen, L. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02166-x · Cited by 132 · cited 1×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodEfficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder
Halbreich, U. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02326-8 · Cited by 123 · cited 1×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodPremenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
Steiner, M. S. (2000) · PubMed Central · Cited by 111
Self-citationBäckström, T. C., Hansson-Malmström, Y., Lindhe, B.-Å., Cavalli-Björkman, B., & Nordenström, S. (1992) · Contraception · doi:10.1016/0010-7824(92)90006-f · Cited by 92 · cited 2×
“PMDD between women on and those not on hormonal contraceptives is in line with data which suggest that HC may reduce premenstrual physical symptoms but do not effect a statistically significant reduction in psychological symptoms (Backstrom et al., 1992; Graham and Sherwin, 1992; Freeman et al., 2001).”
ResultThe measurement of premenstrual mood symptoms
Steiner, M. S., Streiner, D. L., Steinberg, S. I., Stewart, D. E., Carter, D., Berger, C., Reid, R. L., & Grover, D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00121-9 · Cited by 81 · cited 2×
“There are at least 5 different diaries that have been used in recent years and there is no consensus as to which one is the preferred (Reid, 1985; Mortola et al., 1990; Endicott and Harrison, 1992; Freeman et al., 1996; Steiner et al., 1999.)”
BackgroundMethodSelf-citationFull- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant
Freeman, E. W., Rickels, K., Arredondo, F., Kao, L.-C., Pollack, S. E., & Sondheimer, S. J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00002 · Cited by 75 · cited 1×
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodSMITH, M. J., Schmidt, P. J., & Rubinow, D. R. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00053-5 · Cited by 64 · cited 2×
“It has been suggested that the subjective reporting of severity of symptoms may be the most useful clinical diagnostic indicator of women seeking treatment (Angst et al., 2001) and captures the greatest number of symptomatic women (Smith et al., 2003).”
BackgroundA design for studying the DSM-IV research criteria of premenstrual dysphoric disorder
Gehlert, S. J., & Hartlage, S. A. (1997) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674829709085567 · Cited by 40 · cited 4×
“The results are in line with several recent prospective studies which report a prevalence of PMDD in a range of 4.6 to 8.1% and a prevalence of severe PMS in a range of 12.6% to 31.0% (Gehlert and Hartlage, 1997; Hylan et al., 1999; Angst et al., 2001; Wittchen et al., 2002; Sternfeld et al., 2002).”
BackgroundResultInfluentialTreatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety
Macdougall, M., & Steiner, M. S. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.2.161 · Cited by 6 · cited 2×
“The burden of illness of depression in the workplace has been well documented; findings suggest elevated rates of chronic disability, lost work days and diminished work performance in this population (Greenberg and Birnbaum, 2000; Pearlstein et al., 2000; Macdougall and Steiner, 2003).”
BackgroundSelf-citation
Cited by
Martini, J., Petzoldt, J., Einsle, F., Beesdo-Baum, K., Höfler, M., & Wittchen, H.-U. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.012 · Cited by 356
“Similarly, different trends were reported for the course from pregnancy to postpartum (stable rates: Canals, et al., 2002; increasing rates: Stuart et al., 1998; decreasing rates: Heron, et al., 2004).”
BackgroundPremenstrual dysphoric disorder: Evidence for a new category for DSM-5
Epperson, C. N., Steiner, M., Hartlage, S. A., Eriksson, E., Schmidt, P. J., Jones, I., & Yonkers, K. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081302 · Cited by 361
“Dr. Steiner has served as a consultant for AstraZeneca, Azevan, Bayer Canada, and Servier, has received research grants from the Canadian Institutes of Health Research, and has received honoraria from AstraZeneca and the Society for Women’s Health Research.”
BackgroundSelf-citationO’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E., Halbreich, U., Ismail, K. M. K., et al. (2011) · Archives of Women's Mental Health · doi:10.1007/s00737-010-0201-3 · Cited by 295
“The retrospective assessment of symptoms has limited value, although the Premenstrual Symptoms Screening Tool (PSST) is potentially useful (Steiner et al. 2003).”
BackgroundSelf-citationINDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236
Brennan, I. M., Feltrin, K. L., Nair, N. S., Hausken, T., Little, T. J., Gentilcore, D., Wishart, J. M., Jones, K. L., Horowitz, M., & Feinle-Bisset, C. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00051.2009 · Cited by 226
“, oral contraceptive pill, Depo-Provera, Norplant, hormone-releasing IUDs), who had clinically significant premenstrual syndrome and/or premenstrual dysphoric disorder [as assessed by a modified premenstrual symptom screening tool (49)], or who were pregnant (as assessed by a pregnancy test on a urine sample) were exc…”
Method
Metadata
- Authors
- Steiner, M., Macdougall, M., & Brown, E.
- Affiliations
- St. Joseph’s Healthcare Hamilton (CA)
- Eli Lilly (United States) (US)
- ORCID
- Steiner, M.
- Venue
- Archives of Women's Mental Health
- Published
- 2003-08-01
- Volume
- 6
- Issue
- 3
- Pages
- 203-209
- ISSN
- 1434-1816 (ISSN-L)
- 1435-1102
- OpenAlex
- W2052875910
- Cited by
- 641
- References
- 29
- Citations by year
- 2026: 66 · 2025: 89 · 2024: 58 · 2023: 46 · 2022: 51 · 2021: 42 · 2020: 38 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 25 · 2015: 16 · 2014: 13 · 2013: 21 · 2012: 11
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Women s Mental Health (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- Premenstrual Symptoms Screening Tool, premenstrual dysphoric disorder, premenstrual syndrome, screening tool, DSM-IV diagnostic criteria, primary care, prevalence, women's mental health
- MeSH terms
- Adolescent, Adult, Female, Humans, Mass Screening, Middle Aged, Ontario, Premenstrual Syndrome, Severity of Illness Index, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.